RED-CELL MEMBRANE LIPID-PEROXIDATION IN TRANSFUSION-DEPENDENT B B-THALASSEMIA AND EB-THALASSEMIA

被引：1
|
作者：
LAHIRI, P
BHATTACHARJEE, S
CHANDRA, S
BHATTACHARYA, DK
机构：
来源：
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY | 1990年 / 43卷 / 02期
关键词：
D O I：
10.1016/0885-4505(90)90014-R
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Red cell membrane lipid peroxidation in B and EB thalassemias has been found to increase significantly. The increased iron status of the patients, as revealed by the serum ferritin level, did not have any correlation with lipid peroxidation in either of the groups. © 1990.
引用
收藏
页码：101 / 104
页数：4
相关论文
共 50 条
  • [1] HEALTHCARE RESOURCE UTILIZATION IN THE TREATMENT OF TRANSFUSION-DEPENDENT B-THALASSEMIA
    Knoth, R. L.
    Gupta, S.
    Perkowski, K.
    Costantino, H.
    Inyart, B.
    Ashka, L.
    Clapp, K.
    Price, K.
    VALUE IN HEALTH, 2022, 25 (07) : S411 - S411
  • [2] LENTIGLOBIN GENE THERAPY IN PEDIATRICS, ADOLESCENTS, ADULTS WITH TRANSFUSION-DEPENDENT B-THALASSEMIA
    Kwiatkowski, Janet
    Walters, Mark
    Locatelli, Franco
    Lal, Ashutosh
    Yannaki, Evangelia
    Kulozik, Andreas
    Sauer, Martin
    Porter, John
    Thuret, Isabelle
    Hongeng, Suradej
    Thrasher, Adrian
    Olson, Timothy
    Schneiderman, Jennifer
    Elliot, Heidi
    Tao, Ge
    Liu, Weijian
    Colvin, Richard
    Thompson, Alexis
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S31 - S31
  • [3] Betibeglogene Autotemcel (Beti-Cel; Lentiglobin for B-Thalassemia) Gene Therapy Treatment of A Greek Patient with Transfusion-Dependent B-Thalassemia (TDT)
    Constantinou, Varnavas
    Papayanni, Penelope
    Mallouri, Despoina
    Batsis, Ioannis
    Sotiropoulos, Damianos
    Bouinta, Asimina
    Papadopoulou, Despoina
    Papadimitriou, Vasiliki
    Kammenou, Maria
    Liu, Weijian
    Colvin, Richard
    Sakellari, Ioanna
    Anagnostopoulos, Achilles
    Yannaki, Evangelia
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 215 - 216
  • [4] Metabolic Profile & Body Composition in Egyptian Children with Transfusion-Dependent Egyptian B-Thalassemia
    Elalfy, Mohsen Saleh
    Ebeid, Fatma Soliman Elsayed
    Yasmin, El Gendy
    Islam, Elghamry
    Amna, Kalifa
    BLOOD, 2018, 132
  • [5] HTLV-III NEUTRALIZING ANTIBODY DEVELOPMENT IN TRANSFUSION-DEPENDENT SEROPOSITIVE PATIENTS WITH B-THALASSEMIA
    ROBERTGUROFF, M
    GIARDINA, PJ
    ROBEY, WG
    JENNINGS, AM
    NAUGLE, CJ
    AKBAR, AN
    GRADY, RW
    HILGARTNER, MW
    JOURNAL OF IMMUNOLOGY, 1987, 138 (11) : 3731 - 3736
  • [6] RED-CELL ACID-PHOSPHATASE POLYMORPHISM IN GREEK B-THALASSEMIA PATIENTS
    KALOS, A
    MELISSINOS, K
    ARCHIMANDRITIS, A
    KOUROUNIS, G
    ANGELOPOULOS, B
    ACTA GENETICAE MEDICAE ET GEMELLOLOGIAE, 1975, 24 (3-4): : 337 - 338
  • [7] ENDOTHELIAL DYSFUNCTION IN YOUNG TRANSFUSION DEPENDENT B-THALASSEMIA PATIENTS
    Adly, A.
    Elsherif, N.
    Ismail, E.
    Ibrahim, Y.
    Farouk, A.
    HAEMATOLOGICA, 2013, 98 : 694 - 694
  • [8] ASSESSMENT OF IRON ACCUMULATION IN CHILDREN WITH TRANSFUSION DEPENDENT B-THALASSEMIA
    Smetanina, N. S.
    Tereshchenko, G., V
    Krasilnikova, M., V
    Gvozdev, A. A.
    Ibragimova, D. I.
    Mitrofanova, A. M.
    Lokhmatova, M. E.
    Novichkova, G. A.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2016, 61 (01): : 42 - 48
  • [9] LENTIGLOBIN GENE THERAPY IN TRANSFUSION-DEPENDENT B-THALASSEMIA PATIENTS WITH NON-β0/β0 GENOTYPES
    Olson, Timothy
    Walters, Mark
    Kwiatkowski, Janet
    Hongeng, Suradej
    Rasko, John
    Porter, John
    Sauer, Martin
    Thrasher, Adrian
    Thuret, Isabelle
    Schiller, Gary
    Elliot, Heidi
    Deary, Briana
    Chen, Ying
    Tao, Ge
    Asmal, Mohammed
    Locatelli, Franco
    Thompson, Alexis
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [10] HEALTH STATE UTILITIES ASSOCIATED WITH TREATMENT FOR TRANSFUSION DEPENDENT B-THALASSEMIA
    Matza, L. S.
    Paramore, C.
    Stewart, K. D.
    Syrad, H.
    Jobanputra, M.
    Dietz, A.
    VALUE IN HEALTH, 2018, 21 : S469 - S469
12345